ANGIODYNAMICS INC (ANGO)

AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event

Notable Monday Option Activity: X, ANGO, CVNA

AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation

AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System

AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver

AngioDynamics is Now Oversold (ANGO)

AngioDynamics Breaks Below 200-Day Moving Average - Notable for ANGO

Why AngioDynamics Stock Is Crashing Today

Investors didn't like the medical technology company's fiscal 2025 Q1 update.

AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results

AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes

AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024

AngioDynamics Announces CE Mark Approval in Europe for the Auryon System

AngioDynamics to Participate in Upcoming Investor Conferences

Bullish Two Hundred Day Moving Average Cross - ANGO

ANGO Stock Earnings: AngioDynamics Beats EPS, Beats Revenue for Q4 2024

ANGO stock results show that AngioDynamics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024.

AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results

AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024

AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System

AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions

Tuesday 4/9 Insider Buying Report: ZUMZ, ANGO

ANGO Stock Earnings: AngioDynamics Misses EPS, Misses Revenue for Q3 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips AngioDynamics (NASDAQ:ANGO) just reported results for the third quarter of 2024...